YOUR BUSINESS AUTHORITY
Springfield, MO
AstraZeneca entered into an oncology collaboration with Daiichi Sankyo Co. that's worth up to $6 billion.
MarketWatch reports the deal could redefine treatment standards in lung, breast and multiple other cancers.
AstraZeneca initially will pay Daiichi Sankyo $1 billion.
Read more from MarketWatch.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Timeshare exit company owner sentenced for tax evasion
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.